aspirin + clopidogrel + statin + enoxaparin + streptokinase

This is a combination therapy consisting of five pharmacological agents commonly used in the acute management of acute coronary syndromes (ACS), particularly ST-elevation myocardial infarction (STEMI). The regimen includes: - **Aspirin** (an antiplatelet agent that irreversibly inhibits cyclooxygenase-1, reducing thromboxane A2 and platelet aggregation) - **Clopidogrel** (a P2Y12 receptor antagonist that inhibits ADP-mediated platelet activation and aggregation) - **Statin** (HMG-CoA reductase inhibitor, lowers cholesterol and stabilizes atherosclerotic plaques) - **Enoxaparin** (a low molecular weight heparin anticoagulant that potentiates antithrombin III to inhibit factor Xa)[1][6] - **Streptokinase** (a fibrinolytic agent that activates plasminogen to dissolve clots) This combination targets multiple pathways involved in thrombosis, inflammation, and plaque stabilization. It is typically used as part of guideline-directed medical therapy for patients with STEMI or high-risk ACS.

Other names

aspirin, clopidogrel, statin, enoxaparin, streptokinase-University of Colombo-Acute Coronary Syndrome-Unstable Angina-Non ST Elevation Myocardial InfarctionACSSLAP regimen